In a surprise shift, Tony Coles taps his successor as CEO of Bain startup Cerevel

In a move that’s likely to take quite a few industry insiders by surprise, four-time biotech CEO Tony Coles is handing the reins at Cerevel to Ron Renaud, a partner at Bain, which created the neurosciences company out of Pfizer as it bowed out of the field.

But he...

Click to view original post